Aminophylline market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Aminophylline market is segmented By Route of Administration (Oral, Injections), By Applications (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Infant apnea) and Geography.

Aminophylline market Snapshot

Aminophylline market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Aminophylline market is expected to register a CAGR of 2% during the forecast period. This is attributing to increasing incidences of a respiratory disorder, rise in demand for cost-effective treatment. Aminophylline is caffeine-like drugs also known as bronchodilators used for the treatment of respiratory diseases such as Asthma and Chronic obstructive pulmonary diseases. As respiratory diseases are one of the leading causes of death according to World Health Organization (WHO), aminophylline drugs help in diagnosing the population with these disorders. Moreover, Rapid innovation in the field of personalized medicines with technological advancements will also propel the Aminophylline market. As Aminophylline is widely used in a patient experiencing acute exacerbations of COPD leading to boost the market. Furthermore, as per Global Asthma report, in 2018 with the growing number of chronic respiratory disease patients affecting more than one billion people globally, hence results in the adoption of these drugs combination for diagnosis and treatment and then boosts the Aminophylline market.

Scope of the Report

Aminophylline is a drug combination that contains theophylline and ethylenediamine. It helps to prevent and treat wheezing, shortness of breath and lung diseases. The aminophylline market is segmented By Route of Administration, Applications, and Geography.

By Route of Administration
Oral
Injections
By Applications
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Infant Apnea
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Chronic Obstructive Pulmonary Disease (COPD) segment in Aminophylline Market is Expected to Witness a Healthy Growth in Future.

Chronic Obstructive Pulmonary Disease is expected to witness healthy growth in the future owing to the growing number of respiratory disorders and infections worldwide. COPD is a type of lung disease that blocks airflow and makes it difficult to breathe. Aminophylline helps in improving the contraction of the diaphragm and protecting the airway from irritant along with anti-inflammatory actions by relaxing lung muscles, thus helps in diagnosing the respiratory diseases. The rising number of the patient pool leading to the adoption of these drugs combination and further drives the segment growth.

Aminophylline Market.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global Aminophylline market due to the increasing aging population, rising lung diseases, the introduction of new drugs, technological advancements, increasing healthcare expenditure and the presence of well-established healthcare infrastructure. The Global Burden of Disease Study reports a prevalence of 251 million cases of COPD globally in 2016. This incidence of respiratory disorders is leading to promotes the growth of the Aminophylline market.

Aminophylline Market.png

Competitive Landscape

The Aminophylline market is moderately competitive and consists of several international as well as local players. Some of the companies which are currently dominating the market are Pfizer Inc., Omega Laboratories, Merck KGaA, Torque Pharma, Endo International, AGP Limited and ACTIZA PHARMACEUTICAL.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Incidence of Respiratory Disorders

      2. 4.2.2 Rise in Demand of Cost Effective Treatment

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects of the Drug

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Route of Administration

      1. 5.1.1 Oral

      2. 5.1.2 Injections

    2. 5.2 By Applications

      1. 5.2.1 Chronic Obstructive Pulmonary Disease (COPD)

      2. 5.2.2 Asthma

      3. 5.2.3 Infant Apnea

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Clinics

      3. 5.3.3 Ambulatory Surgical Centers

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Pfizer Inc.

      2. 6.1.2 Omega Laboratories

      3. 6.1.3 Merck KGaA

      4. 6.1.4 Abcam

      5. 6.1.5 Endo International

      6. 6.1.6 AGP Limited

      7. 6.1.7 ACTIZA PHARMACEUTICAL

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Aminophylline market market is studied from 2018 - 2026.

The Aminophylline market is growing at a CAGR of 2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Pfizer Inc., Omega Laboratories, Merck KGaA, Torque Pharma, Endo International, ACTIZA PHARMACEUTICAL are the major companies operating in Aminophylline market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!